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Abstract 
The polyamines putrescine (Put), spennidine (Spd), and spennine (Spm), occur in 
all eukaryotic cells and play an important roles in cell growth and differentiation. 
Cadaverine (Cad) also appears in the human body. Polyamines and their metabolites are 
considered to be involved in the process of cel1 multiplication and its regulation. Rapidly 
growing tissues have higher amounts of polyamines and they have a stimulating effect on 
DNA, RNA and protein synthesis. Conversely, severe depletion of polyamines will 
reduce growth in mammalian cells. 
The analysis of polyamines is carried out by an extraction from tissue to isolate 
polyamines. Then this extract is reacted with a pyrene-Iabeling reagent that fonns 
intramolecular excimers so that it might be observed by fluorescence during HPLC 
assays. Through analysis of these peaks and taking into account the amount of sample 
and the concentrations used and injected, one is able to predict the amount of each 
polyamine in the sample. 
These assays and reactions are carried out on mouse leg muscle over a 5-day 
period to see what the levels of polyamines are in them. It is not seen as conclusive as to 
whether there is a predictable degradation timeline for polyamines in mice however 
further experimentation might provide better results. 
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PuRPOSE 
The purpose of this project was to analyze the presence of polyamines in the 
human body postmortem to determine what relation, if any, there is to their presence and 
the rate of decomposition. These findings might provide insight to a timescale of 
decomposition on a biochemical level, rather than on a gross anatomical one. Since an 
opportunity to sample a body did not present itself, it is believed that an analysis in mice 
would provide a similar study and might provide insight into that of the human body. 
These findings in respect to the human body could be useful to help establish another 
way to determine the time since death based on the levels of polyamines. Since many 
pathologists disregard the body after there is a great deal of soft tissue decomposed, it is 
believed that this might provide a useful timeline after that. 
INTRODUCTION 
The polyamines putrescine (Put), spermidine (Spd), and spermine (Spm), occur in 
all eukaryotic cells and play an important roles in cell growth and differentiation. 
Cadaverine (Cad) also appears in the human body! It has been found that the 
concentration of these polyamines together with that of their acetyl conjugates increase 
significantly in the biological fluids and the affected tissues of cancer patients. 
Polyamines and their metabolites are considered to be involved in the process of cell 
multiplication and its regulation.2.3 Rapidly growing tissues have higher amounts of 
polyamines and they have a stimulating effect on DNA, RNA and protein synthesis. 
Conversely, severe depletion of polyamines will reduce growth in mammalian cells.4,S 
Polyamines are reported to have a role in the prevention of nerve damage6,7 and duodenal 
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mucosal repair.8 Spermine has been recommended for the treatment of human prostate 
cancer by itself and in combination with other anticancer drugs.9,lo Put, Cad, Spd, and 
Spm are polycations under physiological conditions and exhibit net charges of 2+,2+, 
3+, and 4+, respectively. As polycations, they could interact electrostatically with 
negatively charged moieties such as DNA, RNA, proteins, and phospholipids and 
stabilize their structure. Spd and Spm are particularly flexible and have charge 
distributions along the whole molecule, this facilitating greater interaction with the 
negatively charged backbone of DNA.ll,12 Free and acetylated Spd, Spd and their 
precursor Put have been reported in mammalian tissue, serum, urine, and the central 
nervous system.13 Cad is produced by the decarboxylation of lysine and has been 
considered to have a role in prokaryotic cells. 
The names and structures are as follows: 
Putrescine 
(put) 
H2N(CH2)2NH2 
1,4 
Diaminobutane 
Cadaverine 
(Cad) 
H2N(CH2)3NH2 
1,5-
Diaminobutane 
Spermidine 
(Spd) 
H2N(CH2)3NH( 
CH2)4NH2 
Spermine 
(Spm) 
H2N(CH2)3NH( 
CH2)4NH(CH2)3 
NH2 
~"'H .. 
..... 
All eukaryotic cells synthesize Put, Spd, and Spm and contain a low level of Put 
and higher levels of Spd and Spm.14 The principal precursors of the polyamines are amino 
acids L-ornithine and L-methionine. The initial hydrolysis of L-arginine to L-orntithine 
and urea, catalyzed by arginase may also be considered. Put is formed by direct 
decarboxylation of L-ornithine. The reaction is catalyzed by ornithine decarboxylase 
(ODC) and may be a rate-determining step in polyamine synthesis in nonproliferating 
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cells. However, in rapidly dividing cells (e.g. embryonal cells, cells of gut mucosa, and 
tumor cells) ODe actively is higher and is not considered a rate-limiting parameter!5,16 
ODe activity is dependent on pridoxial 5' -phosphate for its catalytic activity with a short 
half-life of 20 minutes. 
Spd and Spm are synthesized from Put by the action of spermidine synthase and 
spermine synthase, where the reaction involves the addition of aminopropyl to Put or 
Spd. The aminopropyl groups are derived ultimately from L-methionine. Polyamine is 
catabolized and degraded back to Put by the action of polyamine oxidase and 
spermidine/spermine N' -acetyltransferase. The activity of acetyl trasnferase is low under 
normal conditions and might be attributed to being a rate-limiting factor in the 
interconversion .. The activity of the acetyl transferase can be induced by introducing 
exogenous polyamines.4,14,17 
The analysis of polyamines is carried out by an extraction from tissue to isolate 
polyamines. Then this extract is reacted with a pyrene-Iabeling reagent that forms 
intramolecular excimers so that it might be observed by fluorescence during HPLC 
assays. Through analysis of these peaks and taking into account the amount of sample 
and the concentrations used and injected, one is able to predict the amount of each 
polyamine in the sample. 
PROCEDURE 
Before any analysis is performed it is important to familiarize oneself with the 
techniques and protocols required to perform the assays. To do this, one should perform 
the derivations and reactions on standards of each of the polyamines. The pyrene-
labeling reagent used is 4-(I-Pyrene)butyric acid N-hydroxysuccinimide ester (PSE), 
obtained from Molecular Probes Inc. (Eugene, OR). Distilled water is used for all 
aqueous solutions and any organic solvents used were of HPLC grade. Stock solutions 
(lOmM) of the amines are prepared in a mixture of tetrahydrofuran (THF), dimethyl 
sulfoxide (DMSO), and water (1:2:1, v/v) and are stored at - 80 0c. These are further 
diluted with the solvent mixture before use to obtain the appropriate concentrations. A 
5nM solution of PSE is prepared in acetonitrile and is stored at - 80 °C where it is 
useable for at least a week. 
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Once all reagents are made, one can then perform the pyrene labeling. This is 
done in Reacti-vials where 60 I-lL of 5mM PSE is placed in the vial, followed by 60 I-lL of 
each stock solution (10mM) of polyamine. To this, add 3.5 I-lL of 1M sodium carbonate 
so the reaction can run at the desired pH. The reaction is to be done in a block heater at 
100 °C for 30 minutes. The vials are then placed in an ice water bath and can be stored in 
a - 20°C freezer until HPLC is performed on them.18 
HPLC was performed on an Agilent HPLC system with gradient mixer and CIS 
reverse-phase column rather than the prescribed Cs. The column is washed before the run 
so that it will provide a clean run. For each HPLC run, 10 I-lL of the polyamine standard 
was injected. An elution gradient of 50 %- 100% Acetonitrile is used and a flow rate of 
1 mUmin is established. Elution is monitored at 220 nm, 254 nm, 375 nm, and 475 nm 
and fluorescence was monitored with an excitation and emission wavelength of 345 nm. 
Each run takes approximately 30 minutes or longer and this is performed on each of the 
standards, along with a reaction blank and a monoamine standard. 
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Once all standards are run with good results obtained, tissue sampling 
commenced. The original choice for tissue samples was postmortem human tissue from a 
fresh body (within 24 hours of death). When this did not work out, mice became the 
second option. For the purposes of this project, it was established that a 5-day timescale 
for death would be appropriate and it was also determined that 2 replicates would be 
sufficient. Once this was established, 6 mice were killed and then the four for days 2 and 
5 were set aside and placed in a desiccators jar. The 2 for day 1 were dissected and the 
rear leg muscles for each were removed and place in their respective marked tubes. We 
also removed the livers and placed them in their respective tubes. Once samples were 
collected, they were placed on dry ice to quick freeze them in their state and then these 
were placed in the -80 °C freezer until all samples are collected. This was repeated for 
days 2 and 5 and with all dissection being done in a hood with vertical laminar flow so as 
to prevent contamination and to keep down the smell. All mice used were approved for 
scientific use and were already scheduled to be killed. 
Once all samples were collected, we started extracting the polyamines from each 
sample through a relatively extensive process. It was determined that the most 
reasonable extraction would involve the use of 80% methanol solution that would allow 
the solubility of the polyamines. To accomplish this, eppendorf tubes with micropestels 
seemed to be the best solution to grind up the tissue samples. A portion of each sample 
was taken from each tube and placed in the eppendorf tube and then each was ground to a 
pulp and set on dry ice and then ground again. Then,.5 mL of 80% methanol was added, 
ground again and then the micropestel is rinsed over the tube with another .5 mL of 80% 
methanol solution. This is then vortexed for approximately 30 seconds and then the 
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sample is centrifuged for 5 min. at 14000 min-to The supernatant is then poured off into a 
labeled tube and a small pinhole poked into the top and the samples are placed into 
SpeedVac to evaporate for approximately 45 min. until solution is brought to lOOx. Once 
this is done, the pyrene labeling reaction is performed on each sample under the 
conditions previously noted and then these samples are run through the HPLC system 
with each run taking approximately 1 hour. Once all samples are run, the data is 
collected and the excitation peaks and fractional peaks are analyzed, it is determined what 
polyamines came out at what time based on the standards, which were run earlier. 
RESULTS 
The following chromatograms serve as a summary of the results obtained through 
the analyses performed by HPLC. The rest of the data is taken from the other 
chromatograms. All polyamine standards were run at the same time and then all tissue 
samples were run at the same time. 
Figure 1. Chromatogram at 254 nm illustrating 
the collection time for each fraction of the 
standards polyamines on a CIS column. 
Figure 2. Chromatogram at 345 nm illustrating 
fluorescence for the polyamine standard 
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10mM 10 ul inj Area of Grams per Micrograms/unit Sample MW(g/mol) grams/L grams peak unit area area injected 
Spermine 348.2 3.482 0.00003482 11020.7 3.15951E-09 0.00315951 
Spermidine 254.63 2.5463 0.000025463 9802.17 2.59769E-09 0.00259769 
Cadaverine 175.1 1.751 0.00001751 7648.64 2.2893E-09 0.0022893 
Putrescine 161.08 1.6108 0.000016108 1239.23 1.29984E-08 0.01299839 
Figure 3. Calculations for determining the amount of standard polyamine representing each unit of area 
determined by the amount injected of each standard. 
Polyamine obs. Int. area ugper20ulofsample ug per mg tissue 
m1d1 calculations 
spd 9388.6 29.66336548 3.115899736 
spm 0 
put 0 
cad 5571.5 12.75481197 1.339791173 
m2d1 calculations 
spd 3327.7 10.51389785 1.104401034 
spm 0 
put 0 
cad 1035.7 2.371023738 0.249057115 
m3d2 calculations 
spd 6178.2 19.52007803 2.050428365 
spm 0 
put 1107.3 14.39312186 1.511882548 
cad 603.3 1.381132201 0.145076912 
m4d2 calculations 
spd 1.00E+04 3.16E+01 3.318811895 
spm 0 
put 0 
cad 1073.2 2.456872333 0.258074825 
m5d5 and m6d5 
No measurable polyamines detected 
Figure 4. Calculations from chromatograms to quantify the amount of each polyamine in each 
tissue sample based on the polyamine standards and a 20 ~L sample injection. 
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Other chromatograms performed on the mouse muscle samples are attached at the end to 
refer to see where the information presented in Figures 4 & 5 was taken. These 
chromatograms are at 254 nm and can be compared to the standards in Figure 1. 
DISCUSSION 
According to Fig. 1 and Fig. 2, it is apparent that the pyrene-Iabeling reagent 
worked to fluoresce the polyamines through HPLC analysis showing that the fraction of 
each of the polyamine standards matched with the fluorescence showing 
superimposability. This would suggest that HPLC of polyamines is possible and that it 
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can accurately detect them in solution as the peaks of the mixture match up with those of 
the individual runs of each standard. 
Fig. 3 helps by integrating the peaks of each of the polyamine standards to give a 
baseline to compare the findings from the tissue samples from each of the mice. With 
these findings, it is possible to calculate as illustrated in Fig. 4 the amount of each 
polyamine that is represented in each peak of the chromatogram at each time point. From 
this, one can create a graph to predict the degradation of polyamines in tissue samples of 
mice as is illustrated in Fig. 5. 
The results of this experiment turned out to be somewhat inconclusive. There are 
many possible explanations for these findings. The findings for the tissue samples 
revealed that the amount of polyamines in each sample varied even between replicates 
and that there is not enough evidence to point that one is more correct than the other. 
More replicates would help to achieve this better. Another key aspect to observe is that 
in any given chromatogram of the tissue samples, not all polyamines are observed in any 
noticeable amount. It would seem that all four polyamines would show up, but this does 
not seem to be the case. There was also found to be an error in the extraction process in 
that it is necessary to deproteinate the sample before carrying out the reaction, which was 
not done here. 19 More information regarding the baseline levels of polyamines in mice 
would have also served as indicators of the results obtained. Ideally, collection would 
have produced better results had all samples been taken from the same corpse. This was 
not possible due to the size of the mouse and the amount of tissue needed to carry out the 
extraction. Had this research been done on a human cadaver, it might have been possible 
to sample the same tissue over a longer period of time to cut out certain variables, which 
were experienced here as the mice varied in muscle composition and overall size. 
Another variable that might come into play is that of variability due to cancer as 
polyamines with their acetyl conjugates increase significantly in biological fluids and 
affected tissues of cancer patients.20 This might be more of an issue when researching 
humans. 
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The next step in research would be to start with a broader sampling group using 
mice of similar size and health and increasing the number of replicates to allow for a 
more accurate average. Extraction should be done with a de-proteinating step as well. It 
might also work well to sample the livers after killing the microbes to see if they exhibit a 
different mix of polyamines. The ideal step would be to carry out these assays on the 
human body tissue peri mortem and post mortem over a timescale using several replicates 
to see if the levels from the assays are indicative of a trend in degradation that might lead 
to a new technique in establishing time since death on a biochemical level. 
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